In parallel with the visit of HRH Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister of Saudi Arabia, to the United States, the Royal Commission for Riyadh City (RCRC) participated in the U.S.-Saudi Investment Forum 2025. During the forum’s sessions, senior leaders from RCRC’s health sector highlighted the key role of biotechnology, research, and innovation in promoting Riyadh’s position on the global healthcare landscape. They also highlighted the value of international collaboration and partnerships in developing world-class medical, research, and academic capabilities that enhance quality of life.

As part of its engagement at the forum, RCRC announced the signing of two landmark memorandums of understanding (MoUs) with the renowned Cleveland Clinic and Mass General Brigham, an affiliate of Harvard Medical School. These agreements align with RCRC’s strategic mission to attract international leading medical institutions and establish cutting-edge healthcare and research centers in the Saudi capital. The initiatives are set to strengthen Riyadh’s healthcare ecosystem, advance medical education and research, and contribute to improved health outcomes – reinforcing the city’s standing as a leading global hub for advanced medical care and scientific innovation.